Efficacy Results of Pimavanserin from a Multi-Center, Open-Label Extension Study in Parkinson's Disease Psychosis Patients
AuthID
P-00T-XB0
P-00T-XB0
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service